Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Cash Flow-to-Debt Ratio
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow-to-Debt Ratio of 0.70x as of September 2025, meaning its operating cash flow of CN¥504.02 Million could theoretically repay 1% of its total liabilities (CN¥719.98 Million) in one year. See financial agility of Chengdu Kanghong Pharmaceuticals Group C to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see 002773 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year debt coverage analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. Check Chengdu Kanghong Pharmaceuticals Group C (002773) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 2.33x | CN¥1.50 Billion | CN¥645.22 Million | ▲ +14.7% |
| 2024 | 2.03x | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.7% |
| 2023 | 1.70x | CN¥1.22 Billion | CN¥717.76 Million | ▲ +49.3% |
| 2022 | 1.14x | CN¥925.15 Million | CN¥813.85 Million | ▲ +95.8% |
| 2021 | 0.58x | CN¥494.11 Million | CN¥851.08 Million | ▲ +164.9% |
| 2020 | 0.22x | CN¥273.32 Million | CN¥1.25 Billion | ▼ -67.4% |
| 2019 | 0.67x | CN¥812.15 Million | CN¥1.21 Billion | ▲ +113.1% |
| 2018 | 0.32x | CN¥350.88 Million | CN¥1.11 Billion | ▼ -57.1% |
| 2017 | 0.74x | CN¥766.86 Million | CN¥1.04 Billion | ▼ -25.9% |
| 2016 | 0.99x | CN¥846.35 Million | CN¥853.27 Million | ▼ -22.6% |
| 2015 | 1.28x | CN¥481.97 Million | CN¥376.19 Million | ▲ +44.7% |
| 2014 | 0.89x | CN¥291.38 Million | CN¥329.11 Million | ▼ -18.8% |
| 2013 | 1.09x | CN¥333.31 Million | CN¥305.69 Million | ▲ +45.2% |
| 2012 | 0.75x | CN¥281.84 Million | CN¥375.39 Million | ▲ +59.9% |
| 2011 | 0.47x | CN¥168.86 Million | CN¥359.58 Million | ▲ +25.7% |
| 2010 | 0.37x | CN¥136.79 Million | CN¥366.21 Million | ▼ -2.3% |
| 2009 | 0.38x | CN¥108.42 Million | CN¥283.73 Million | — |